[A medical commentary on the approval of RU-486]

Rev Med Univ Navarra. 1998 Oct-Dec;42(4):226-7.
[Article in Spanish]
No abstract available

MeSH terms

  • Abortifacient Agents, Nonsteroidal / adverse effects
  • Abortifacient Agents, Steroidal* / adverse effects
  • Drug Approval*
  • Ethics, Medical
  • Female
  • Health Policy*
  • Humans
  • Mifepristone* / adverse effects
  • Misoprostol / adverse effects
  • Pregnancy
  • Spain

Substances

  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Misoprostol
  • Mifepristone